Body

Iron deficiency may increase stroke risk through sticky blood

Scientists at Imperial College London have discovered that iron deficiency may increase stroke risk by making the blood more sticky.

The findings, published in the journal PLOS ONE, could ultimately help with stroke prevention.

Every year, 15 million people worldwide suffer a stroke. Nearly six million die and another five million are left permanently disabled. The most common type, ischaemic stroke, occurs because the blood supply to the brain is interrupted by small clots.

Bevacizumab offers no benefit for newly diagnosed glioblastoma, MD Anderson-led study finds

HOUSTON — The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.

The study appears in the New England Journal of Medicine, and was first presented on the plenary session of the American Society of Clinical Oncology 2013 Annual Meeting by Mark Gilbert, M.D., professor in MD Anderson's Department of Neuro-Oncology.

Bevacizumab (Avastin) fails to improve survival for newly diagnosed glioblastoma patients

BALTIMORE – February 19, 2014. Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.

Clutter cutter

WASHINGTON D.C. Feb. 19, 2014 -- Life can be messy at all scales, requiring different organizational strategies -- from cleaning the house, to removing damaged or expired cells from the body to avoid cancer progression.

HPV vaccination is associated with reduced risk of cervical lesions in Denmark

A reduced risk of cervical lesions among Danish girls and women at the population level is associated with use of a quadrivalent HPV vaccine after only six years, according to a new study published February 19 in the Journal of the National Cancer Institute.

Whole genome analysis, stat

Although the time and cost of sequencing an entire human genome has plummeted, analyzing the resulting three billion base pairs of genetic information from a single genome can take many months.

In the journal Bioinformatics, however, a University of Chicago-based team—working with Beagle, one of the world's fastest supercomputers devoted to life sciences—reports that genome analysis can be radically accelerated. This computer, based at Argonne National Laboratory, is able to analyze 240 full genomes in about two days.

Study shows in vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia

DOWNERS GROVE, Ill. – February 19, 2014 – New research shows that the addition of confocal laser endomicroscopy to high-definition white-light endoscopy enables improved real-time endoscopic diagnosis of Barrett's esophagus dysplasia (neoplastic tissue) by using targeted biopsies of abnormal mucosa to reduce unnecessary mucosal biopsies and potentially reduce costs. It may also positively influence patient care by changing the plan for immediate endoscopic management.

Molecular aberration signals cancer

Several scientists, including one at Simon Fraser University, have made a discovery that strongly links a little understood molecule, which is similar to DNA, to cancer and cancer survival.

EMBO Reports, a life sciences journal published by the European Molecular Biology Organization, has just published online the scientists' findings about small non-coding RNAs.

Graduate student makes major discovery about seal evolution

Ottawa, February, 19, 2014—In the world of science, one of the most exciting things a researcher can do is pin down an answer to a widely asked question. This experience came early for Carleton University graduate Thomas Cullen, who made a discovery about pinnipeds—the suborder that makes up seals, sea lions and walruses—while doing research for his Master's degree under the supervision of Canadian Museum of Nature palaeontologist Dr. Natalia Rybczynski.

Cell therapy shows remarkable ability to eradicate cancer in clinical study

NEW YORK, February 19, 2014 — Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells. The results were published today in Science Translational Medicine.

LGBT youth face greater cancer risks, CCNY-led study

A new study led by City College of New York psychologist Margaret Rosario found that youths of same-sex orientation are more likely to engage in behaviors associated with cancer risk than heterosexuals. The peer-reviewed findings appear in the February 2014 issue of the American Journal of Public Health.

Huntington's disease: Hot on the trail of misfolded proteins' toxic modus operandi

WASHINGTON D.C. Feb. 19, 2014 -- Proteins are the workhorses of the cell, and their correctly folded three-dimensional structures are critical to cellular functions. Misfolded structures often fail to properly perform these vital jobs, leading to cellular stress and devastating neurodegenerative disorders such as Alzheimer's, Parkinson's and Huntington's disease.

Blood pressure medications given right after stroke not beneficial, study finds

MAYWOOD, IL – A major study has found that giving stroke patients medications to lower their blood pressure during the first 48 hours after a stroke does not reduce the likelihood of death or major disability.

The study is published in the Journal of the American Medical Association.

Rutgers scientists identify structure of virus that could lead to hepatitis C vaccine

Rutgers University scientists have determined the structure of a hepatitis C surface protein, a finding that could assist in the development of a vaccine to halt the spread of the the deadly disease that has infected 3.2 million Americans.

Joseph Marcotrigiano, associate professor of chemistry and chemical biology, says this new research – published online today in Nature – describes an outer region of hepatitis C that enables the virus to evade the body's natural immune system response, causing persistent, chronic infection.

Managed honeybees linked to new diseases in wild bees

Diseases that are common in managed honeybee colonies are now widespread in the UK's wild bumblebees, according to research published in Nature. The study suggests that some diseases are being driven into wild bumblebee populations from managed honeybees.